Skip to main content
Clinical Trials/DRKS00013638
DRKS00013638
Completed
Phase 2

Assistant to activate patients with dementia and their caregivers - MobiAssist

Ambulante Diakonische Dienste gGmbH0 sites53 target enrollmentFebruary 1, 2018

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
F00
Sponsor
Ambulante Diakonische Dienste gGmbH
Enrollment
53
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 1, 2018
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Ambulante Diakonische Dienste gGmbH

Eligibility Criteria

Inclusion Criteria

  • 1\) type of dementia: Alzheimer’s disease or vascular dementia; diagnosed by professionals in memory clinic (CERAD neuropsychological battery); alternative for Siegen: Clinical Dementia Rating (CDR; Morris, 1993\) value \> 0\.5
  • 2\) give consent
  • 3\) participants are retired
  • 4\) participants are mobile and able to stand up from a chair without support and walk 6m
  • 5\) care dependency measured by barthel index (BI): criteria: BI\< 60 points (Mahoney \& Barthel, 1965\)
  • 6\) support by a professional caregiver or by an informal caregiver
  • 7\) written informed consent from patient with dementia and the informal caregiver
  • 8\) medical certification
  • 9\) cognitive and social requirements (interested, motivated, no aggressive behavior, can imitate exercises, understand simple verbal information, control of emotional reactions)
  • 10\) physical requirements (routine actions can be completed; also he/she can: see, hear, speak, sit and stand up, walk, grab and hold on a chair)

Exclusion Criteria

  • 1\) other types of dementia (frontotemporal dementia, dementia with Lewy bodies, alcohol\-relates brain damage (Korsakoff´s syndrome), familial Alzheimer's disease)
  • 2\) mental disorders like depression or generalized anxiety disorder who have not been satisfactorily medicated for at least six months; substance\-related disorders in the last 2 years; schizophrenia and other psychological disorders
  • 3\) neurodegenerative diseases of the Central Nervous System (CNS), Parkinson’s disease, multiple sclerosis, Amyotrophic Lateral Sclerosis (ALS)
  • 4\) cardiovascular diseases: acute cardiac failure, acute cardiac insufficiency, angina pectoris, untreated cardiac arrhythmia or heart valve disease, pacemaker, untreated hypertension \- systolic blood pressure \>180 mm Hg or diastolic blood pressure \> 110 mm Hg; untreated hypotension \- \< 90/60 mm Hg
  • 5\) untreated cancer disease
  • 6\) untreated hormone diseases
  • 7\) badly controlled diabetes (blood glucose \< 6 mmol/L or \>15 mmol/L)
  • 8\) epilepsy
  • 9\) Chronic Obstructive Pulmonary Disease (COPD) grade 4
  • 10\) acute infection or fever

Outcomes

Primary Outcomes

Not specified

Similar Trials